instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Histoplasmosis disseminated'. | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34262987 | 19,810,358 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | METHOTREXATE SODIUM, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34262987 | 19,810,677 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peritonsillar abscess'. | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34262987 | 19,810,358 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34262987 | 19,821,648 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34262987 | 19,821,648 | 2021-07 |
What was the dosage of drug 'METHOTREXATE'? | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | 25 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34262987 | 19,810,358 | 2021-07 |
What was the outcome of reaction 'Histoplasmosis disseminated'? | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | Recovered | ReactionOutcome | CC BY-NC-ND | 34262987 | 19,810,358 | 2021-07 |
What was the outcome of reaction 'Peritonsillar abscess'? | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | Recovered | ReactionOutcome | CC BY-NC-ND | 34262987 | 19,810,358 | 2021-07 |
What was the outcome of reaction 'Tonsillar disorder'? | Gastrointestinal Histoplasmosis Mimicking Crohn's Disease.
Disseminated histoplasmosis is a life-threatening disease usually seen in immunocompromised patients living in endemic areas. We present an apparently immunocompetent patient with gastrointestinal histoplasmosis who was initially diagnosed with biopsy-proven Cr... | Recovering | ReactionOutcome | CC BY-NC-ND | 34262987 | 19,810,677 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.
Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated... | HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34263128 | 20,932,208 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series.
Cardiovascular and thromboembolic complications have been reported in patients with Coronavirus disease-2019 (COVID-19)-related severe respiratory distress syndrome. Although myocarditis associated... | HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34263128 | 20,932,208 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
BACKGROUND
Diffusion-weighted whole-body MRI (DW-MRI) is increasingly u... | CARFILZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 34263564 | 19,914,028 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
BACKGROUND
Diffusion-weighted whole-body MRI (DW-MRI) is increasingly u... | CARFILZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 34263564 | 19,914,028 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
BACKGROUND
Diffusion-weighted whole-body MRI (DW-MRI) is increasingly u... | CARFILZOMIB, DEXAMETHASONE, LENALIDOMIDE | DrugsGivenReaction | CC BY | 34263564 | 19,914,028 | 2021-09 |
What was the outcome of reaction 'Death'? | Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry.
BACKGROUND
Diffusion-weighted whole-body MRI (DW-MRI) is increasingly u... | Fatal | ReactionOutcome | CC BY | 34263564 | 19,914,028 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
BACKGROUND
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication and interaction and restricted, repetitive behaviors. The unmet medical ... | ARIPIPRAZOLE | DrugsGivenReaction | CC BY | 34264367 | 19,916,478 | 2021-09 |
What was the dosage of drug 'RIFAMPIN'? | Unusual Recurrence of Antituberculosis Drug-Induced Hepatotoxicity in Children: A Case Series.
BACKGROUND Antituberculosis drug-induced hepatotoxicity (ADIH) is a possible adverse event of antitubercular treatment. There are still no official guidelines for ADIH management in children. Recurrent ADIH is infrequently re... | UNK, DOSE DECREASED | DrugDosageText | CC BY-NC-ND | 34267172 | 20,168,186 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma.
Chimeric antigen receptor (CAR) T-cell immunotherapy following autologous stem cell transplantation (ASCT) is a promising method for refractory or relapsed multiple myeloma, but explicit data ... | BUSULFAN, CYCLOPHOSPHAMIDE, THIOTEPA | DrugsGivenReaction | CC BY | 34267187 | 19,887,374 | 2021-07-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune effector cell-associated neurotoxicity syndrome'. | Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma.
Chimeric antigen receptor (CAR) T-cell immunotherapy following autologous stem cell transplantation (ASCT) is a promising method for refractory or relapsed multiple myeloma, but explicit data ... | BUSULFAN, CYCLOPHOSPHAMIDE, THIOTEPA | DrugsGivenReaction | CC BY | 34267187 | 19,887,056 | 2021-07-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma.
Chimeric antigen receptor (CAR) T-cell immunotherapy following autologous stem cell transplantation (ASCT) is a promising method for refractory or relapsed multiple myeloma, but explicit data ... | BUSULFAN, CYCLOPHOSPHAMIDE, THIOTEPA | DrugsGivenReaction | CC BY | 34267187 | 19,887,374 | 2021-07-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cushingoid'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,373,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level increased'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised oedema'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperkalaemia'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lethargy'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic syndrome'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,373,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transaminases increased'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,352,760 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | CYCLOSPORINE, DILTIAZEM, PREDNISOLONE, SIMVASTATIN, TELMISARTAN | DrugsGivenReaction | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
What was the administration route of drug 'CYCLOSPORINE'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 34267441 | 19,373,568 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | LOWER THE DOSE OF PREDNISOLONE | DrugDosageText | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | Recovering | ReactionOutcome | CC BY-NC-SA | 34267441 | 19,353,239 | 2021 |
What was the outcome of reaction 'Drug interaction'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | Fatal | ReactionOutcome | CC BY-NC-SA | 34267441 | 19,373,568 | 2021 |
What was the outcome of reaction 'Embolism venous'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | Fatal | ReactionOutcome | CC BY-NC-SA | 34267441 | 19,373,568 | 2021 |
What was the outcome of reaction 'Hyperkalaemia'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | Recovered | ReactionOutcome | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
What was the outcome of reaction 'Transaminases increased'? | First Reported Case of Rhabdomyolysis Associated with Concomitant Use of Cyclosporin, Diltiazem, and Simvastatin.
Rhabdomyolysis is a syndrome with a wide range of symptoms ranging from asymptomatic raised serum creatinine kinase to life-threatening metabolic disturbances and acute kidney injury. A careful history taki... | Recovered | ReactionOutcome | CC BY-NC-SA | 34267441 | 19,359,471 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | ASPIRIN, CLOPIDOGREL BISULFATE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-SA | 34267446 | 19,358,205 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | Recovered | ReactionOutcome | CC BY-NC-SA | 34267446 | 19,361,359 | 2021 |
What was the outcome of reaction 'Hyperkalaemia'? | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | Recovering | ReactionOutcome | CC BY-NC-SA | 34267446 | 19,332,125 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | Recovering | ReactionOutcome | CC BY-NC-SA | 34267446 | 19,332,125 | 2021 |
What was the outcome of reaction 'Myopathy'? | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | Recovered | ReactionOutcome | CC BY-NC-SA | 34267446 | 19,332,125 | 2021 |
What was the outcome of reaction 'Nodal rhythm'? | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | Recovered | ReactionOutcome | CC BY-NC-SA | 34267446 | 19,332,125 | 2021 |
What was the outcome of reaction 'Paraparesis'? | Rosuvastatin-Induced Rhabdomyolysis: A Case Report.
Rosuvastatin is a recently approved statin and used widely across the globe for primary and secondary prevention of atherosclerotic cardiovascular heart disease. It has the highest lipid-lowering property among all statins and relatively well tolerated. Rhabdomyolysis... | Recovered | ReactionOutcome | CC BY-NC-SA | 34267446 | 19,332,125 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.
Encapsulating peritoneal sclerosis (EPS) is an infrequent but serious complication of long-term peritoneal dialysis (PD). EPS may become clinically apparent when patients are on PD (classical EPS) or after undergoing kidney t... | MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY-NC-SA | 34267447 | 19,519,951 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.
Encapsulating peritoneal sclerosis (EPS) is an infrequent but serious complication of long-term peritoneal dialysis (PD). EPS may become clinically apparent when patients are on PD (classical EPS) or after undergoing kidney t... | UNK UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-SA | 34267447 | 19,476,707 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.
Encapsulating peritoneal sclerosis (EPS) is an infrequent but serious complication of long-term peritoneal dialysis (PD). EPS may become clinically apparent when patients are on PD (classical EPS) or after undergoing kidney t... | UNK, UNKNOWN FREQ. | DrugDosageText | CC BY-NC-SA | 34267447 | 19,476,707 | 2021 |
What was the outcome of reaction 'Encapsulating peritoneal sclerosis'? | Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.
Encapsulating peritoneal sclerosis (EPS) is an infrequent but serious complication of long-term peritoneal dialysis (PD). EPS may become clinically apparent when patients are on PD (classical EPS) or after undergoing kidney t... | Recovering | ReactionOutcome | CC BY-NC-SA | 34267447 | 19,476,707 | 2021 |
What was the outcome of reaction 'Pleural effusion'? | Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.
Encapsulating peritoneal sclerosis (EPS) is an infrequent but serious complication of long-term peritoneal dialysis (PD). EPS may become clinically apparent when patients are on PD (classical EPS) or after undergoing kidney t... | Recovering | ReactionOutcome | CC BY-NC-SA | 34267447 | 19,519,951 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic lymphocytic leukaemia'. | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | ADALIMUMAB, APREMILAST, ETANERCEPT | DrugsGivenReaction | CC BY-NC | 34267533 | 19,941,768 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | ADALIMUMAB, APREMILAST, ETANERCEPT | DrugsGivenReaction | CC BY-NC | 34267533 | 20,014,199 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelofibrosis'. | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | APREMILAST, RUXOLITINIB, SECUKINUMAB | DrugsGivenReaction | CC BY-NC | 34267533 | 19,615,556 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Squamous cell carcinoma'. | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | ADALIMUMAB, APREMILAST, ETANERCEPT | DrugsGivenReaction | CC BY-NC | 34267533 | 20,014,199 | 2021 |
What was the dosage of drug 'ADALIMUMAB'? | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | UNKNOWN | DrugDosageText | CC BY-NC | 34267533 | 19,941,768 | 2021 |
What was the dosage of drug 'APREMILAST'? | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | UNKNOWN | DrugDosageText | CC BY-NC | 34267533 | 19,941,768 | 2021 |
What was the dosage of drug 'ETANERCEPT'? | Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic... | UNKNOWN | DrugDosageText | CC BY-NC | 34267533 | 19,941,768 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colorectal cancer metastatic'. | A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy.
Recently, v-raf murine sarcoma viral oncogene homologue B (BRAF) fusions have been identified in multiple cancer types using comprehensive genomic profiling (CGP) assays. BRAF fusions are extremely rare, occurring i... | BEVACIZUMAB, CAPECITABINE, FLUOROURACIL\IRINOTECAN\LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34267639 | 19,990,170 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy.
Recently, v-raf murine sarcoma viral oncogene homologue B (BRAF) fusions have been identified in multiple cancer types using comprehensive genomic profiling (CGP) assays. BRAF fusions are extremely rare, occurring i... | BEVACIZUMAB, CAPECITABINE, FLUOROURACIL\IRINOTECAN\LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 34267639 | 19,990,170 | 2021 |
What was the outcome of reaction 'Colorectal cancer metastatic'? | A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy.
Recently, v-raf murine sarcoma viral oncogene homologue B (BRAF) fusions have been identified in multiple cancer types using comprehensive genomic profiling (CGP) assays. BRAF fusions are extremely rare, occurring i... | Recovering | ReactionOutcome | CC BY-NC | 34267639 | 19,990,170 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure congestive'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholecystitis acute'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal infection'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal obstruction'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial ischaemia'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Perforation'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour lysis syndrome'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | BENDAMUSTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, PREDNISOLONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34267798 | 20,205,743 | 2021 |
What was the outcome of reaction 'Haemorrhage'? | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | Fatal | ReactionOutcome | CC BY | 34267798 | 20,205,743 | 2021 |
What was the outcome of reaction 'Infection'? | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | Fatal | ReactionOutcome | CC BY | 34267798 | 20,205,743 | 2021 |
What was the outcome of reaction 'Tumour lysis syndrome'? | Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma in the elderly and poses unique challenges in this group of patients. There is a need for more information on real-world ou... | Fatal | ReactionOutcome | CC BY | 34267798 | 20,205,743 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | CDK 4/6 inhibitor induced lung injury: a case report and review of literature.
Palbociclib is a cyclin dependent kinase (CDK) 4/6 inhibitor that is indicated in combination with an aromatase inhibitor for first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 -negative advanced or m... | LETROZOLE, PALBOCICLIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 34267801 | 19,526,786 | 2021 |
What was the dosage of drug 'PALBOCICLIB'? | CDK 4/6 inhibitor induced lung injury: a case report and review of literature.
Palbociclib is a cyclin dependent kinase (CDK) 4/6 inhibitor that is indicated in combination with an aromatase inhibitor for first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 -negative advanced or m... | UNK, MONTHLY (3?MONTHLY) | DrugDosageText | CC BY | 34267801 | 19,526,786 | 2021 |
What was the dosage of drug 'ZOLEDRONIC ACID'? | CDK 4/6 inhibitor induced lung injury: a case report and review of literature.
Palbociclib is a cyclin dependent kinase (CDK) 4/6 inhibitor that is indicated in combination with an aromatase inhibitor for first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 -negative advanced or m... | UNK UNK, MONTHLY (3?MONTHLY) | DrugDosageText | CC BY | 34267801 | 19,526,786 | 2021 |
What was the outcome of reaction 'Pneumonitis'? | CDK 4/6 inhibitor induced lung injury: a case report and review of literature.
Palbociclib is a cyclin dependent kinase (CDK) 4/6 inhibitor that is indicated in combination with an aromatase inhibitor for first-line treatment of hormone receptor-positive, human epidermal growth factor receptor 2 -negative advanced or m... | Fatal | ReactionOutcome | CC BY | 34267801 | 19,526,786 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | BENDAMUSTINE, IBRUTINIB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised oedema'. | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | BENDAMUSTINE, IBRUTINIB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | BENDAMUSTINE, IBRUTINIB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | BENDAMUSTINE, IBRUTINIB, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
What was the dosage of drug 'BENDAMUSTINE'? | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | UNK (WITH RITUXIMAB) | DrugDosageText | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
What was the outcome of reaction 'Febrile neutropenia'? | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | Recovered | ReactionOutcome | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
What was the outcome of reaction 'Neutropenia'? | Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Cases of late onset neutropenia (LON) after rituximab therapy have been documented, but few cases have been documented of early onset neutropenia (EON). We present a case report of a patient with mantle cell lymphoma who presented ... | Recovered | ReactionOutcome | CC BY-NC | 34267851 | 19,612,465 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombotic thrombocytopenic purpura'. | A Novel Case of Leflunomide-Induced Thrombotic Thrombocytopenic Purpura.
Leflunomide has not been previously associated with thrombotic thrombocytopenic purpura (TTP), a rare life-threatening clinical syndrome characterized by thrombotic microangiopathy (TMA) due to inability to cleave ADAMTS13. Here, we present the fi... | ASPIRIN, LEFLUNOMIDE, SULFASALAZINE | DrugsGivenReaction | CC BY-NC | 34267852 | 19,626,903 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | A Novel Case of Leflunomide-Induced Thrombotic Thrombocytopenic Purpura.
Leflunomide has not been previously associated with thrombotic thrombocytopenic purpura (TTP), a rare life-threatening clinical syndrome characterized by thrombotic microangiopathy (TMA) due to inability to cleave ADAMTS13. Here, we present the fi... | ASPIRIN, LEFLUNOMIDE, SULFASALAZINE | DrugsGivenReaction | CC BY-NC | 34267852 | 19,626,903 | 2021-06 |
What was the outcome of reaction 'Thrombotic thrombocytopenic purpura'? | A Novel Case of Leflunomide-Induced Thrombotic Thrombocytopenic Purpura.
Leflunomide has not been previously associated with thrombotic thrombocytopenic purpura (TTP), a rare life-threatening clinical syndrome characterized by thrombotic microangiopathy (TMA) due to inability to cleave ADAMTS13. Here, we present the fi... | Recovered | ReactionOutcome | CC BY-NC | 34267852 | 19,626,903 | 2021-06 |
What was the outcome of reaction 'Toxicity to various agents'? | A Novel Case of Leflunomide-Induced Thrombotic Thrombocytopenic Purpura.
Leflunomide has not been previously associated with thrombotic thrombocytopenic purpura (TTP), a rare life-threatening clinical syndrome characterized by thrombotic microangiopathy (TMA) due to inability to cleave ADAMTS13. Here, we present the fi... | Recovered | ReactionOutcome | CC BY-NC | 34267852 | 19,626,903 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death neonatal'. | Management of ovarian immature teratoma grade-II in pregnancy, two cases report and literature review.
Postoperative chemotherapy during pregnancy after first trimester is essential for patients with initial disease stage 1, grade 2 ovarian immature teratoma and it associates with lower disease progression and recurren... | BLEOMYCIN SULFATE, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY | 34267917 | 20,143,304 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eclampsia'. | Management of ovarian immature teratoma grade-II in pregnancy, two cases report and literature review.
Postoperative chemotherapy during pregnancy after first trimester is essential for patients with initial disease stage 1, grade 2 ovarian immature teratoma and it associates with lower disease progression and recurren... | BLEOMYCIN SULFATE, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY | 34267917 | 20,137,887 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Management of ovarian immature teratoma grade-II in pregnancy, two cases report and literature review.
Postoperative chemotherapy during pregnancy after first trimester is essential for patients with initial disease stage 1, grade 2 ovarian immature teratoma and it associates with lower disease progression and recurren... | BLEOMYCIN SULFATE, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY | 34267917 | 20,137,887 | 2021-07 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.